DarioHealth Digital Platform Cuts Hospitalization Rates and Healthcare Costs, Peer-Reviewed Study Finds

Reuters
2025/11/24
<a href="https://laohu8.com/S/DRIO">DarioHealth</a> Digital Platform Cuts Hospitalization Rates and Healthcare Costs, Peer-Reviewed Study Finds

DarioHealth Corp. has announced the publication of a new peer-reviewed study in the Journal of Medical Internet Research evaluating its digital health platform for adults with Type 2 Diabetes Mellitus. The study, conducted by researchers at Sanofi and Symphony Health, compared healthcare utilization and medical costs between Dario users and matched non-users receiving usual care. Results showed that Dario users experienced 23% lower hospitalization rates and 26% lower all-cause medical charges, with an estimated annual medical cost savings of $5,077 per user. The study found that more frequent engagement with the Dario platform was associated with fewer inpatient and emergency room events. The full results are now available and have already been published on the JMIR website.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DarioHealth Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN31137) on November 24, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10